Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Thall

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Biometrics|March 1, 1988
Mixed Poisson likelihood regression models for longitudinal interval count dataP F Thall
Controlled Clinical Trials|December 1, 1994
A Bayesian approach to establishing sample size and monitoring criteria for phase II clinical trialsP F Thall, R Simon
Statistics in Medicine|June 5, 1998
Parametric likelihoods for multiple non-fatal competing risks and deathY Shen, P F Thall
Biometrics|January 5, 2002
Decision-theoretic designs for pre-phase II screening trials in oncologyN Stallard, P F Thall
Biometrics|June 1, 1994
Practical Bayesian guidelines for phase IIB clinical trialsP F Thall, R Simon
Statistics in Medicine|March 1, 1990
Incorporating historical control data in planning phase II clinical trialsP F Thall, R Simon
Biometrics|April 21, 2001
Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trialsP F Thall, S C Cheng
Statistics in Medicine|July 15, 1993
A Bayesian strategy for screening cancer treatments prior to phase II clinical evaluationP F Thall, E H Estey
Statistics in Medicine|January 1, 1986
Assessment of stratum-covariate interactions in Cox's proportional hazards regression modelP F Thall, J M Lachin
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2003
Practical model-based dose-finding in phase I clinical trials: methods based on toxicityP F Thall, S-J Lee
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Biometrics|March 1, 1988
Mixed Poisson likelihood regression models for longitudinal interval count dataP F Thall
Controlled Clinical Trials|December 1, 1994
A Bayesian approach to establishing sample size and monitoring criteria for phase II clinical trialsP F Thall, R Simon
Statistics in Medicine|June 5, 1998
Parametric likelihoods for multiple non-fatal competing risks and deathY Shen, P F Thall
Biometrics|January 5, 2002
Decision-theoretic designs for pre-phase II screening trials in oncologyN Stallard, P F Thall
Biometrics|June 1, 1994
Practical Bayesian guidelines for phase IIB clinical trialsP F Thall, R Simon
Statistics in Medicine|March 1, 1990
Incorporating historical control data in planning phase II clinical trialsP F Thall, R Simon
Biometrics|April 21, 2001
Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trialsP F Thall, S C Cheng
Statistics in Medicine|July 15, 1993
A Bayesian strategy for screening cancer treatments prior to phase II clinical evaluationP F Thall, E H Estey
Statistics in Medicine|January 1, 1986
Assessment of stratum-covariate interactions in Cox's proportional hazards regression modelP F Thall, J M Lachin
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2003
Practical model-based dose-finding in phase I clinical trials: methods based on toxicityP F Thall, S-J Lee
Pageof 6